10/10/24 17:48 | 10/8/24 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -3,756 | 232.22 | 0 | -16 | 0 | 47,740 | M | | | | | | | | | | | | | | |
6/26/24 17:22 | 6/24/24 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -445 | 159.58 | 0 | -3 | 0 | 47,950 | D | | | | | | | | | | | | | | |
6/20/24 17:27 | 6/17/24 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -204 | 159.35 | 0 | -1 | 0 | 47,986 | D | | | | | | | | | | | | | | |
4/11/24 18:01 | 4/9/24 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -7,475 | 149.50 | 0 | -50 | 0 | 47,512 | I | | | | | | | | | | | | | | |
3/14/24 17:23 | 3/12/24 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -8,368 | 167.36 | 0 | -50 | 0 | 48,162 | D | | | | | | | | | | | | | | |
1/12/23 16:52 | 1/10/23 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -5,067 | 248.51 | 0 | -20 | 0 | 48,457 | M | | | | | | | | | | | | | | |
12/29/22 18:24 | 12/27/22 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -2,157 | 224.43 | 0 | -10 | 0 | 48,722 | M | | | | | | | | | | | | | | |
11/17/22 17:10 | 11/15/22 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -6,190 | 206.84 | 0 | -30 | 0 | 48,847 | M | | | | | | | | | | | | | | |
9/22/22 17:34 | 9/20/22 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -7,607 | 152.13 | 0 | -50 | 0 | 49,236 | I | | | | | | | | | | | | | | |
9/16/21 18:06 | 9/14/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -33,788 | 82.04 | 0 | -412 | -1 | 49,552 | D | | | | | | | | | | | | | | |
9/2/21 20:40 | 8/31/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -31,685 | 109.78 | 0 | -289 | -1 | 50,732 | D | | | | | | | | | | | | | | |
8/5/21 21:03 | 8/4/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -16,584 | 132.34 | 0 | -125 | 0 | 52,032 | D | | | | | | | | | | | | | | |
8/5/21 21:01 | 8/3/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -15,202 | 182.37 | 0 | -83 | 0 | 52,663 | D | | | | | | | | | | | | | | |
7/22/21 18:23 | 7/22/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -4,971 | 71.82 | 0 | -69 | 0 | 53,249 | D | | | | | | | | | | | | | | |
7/22/21 18:21 | 7/20/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -10,779 | 152.13 | 0 | -71 | 0 | 53,454 | D | | | | | | | | | | | | | | |
7/8/21 19:11 | 7/8/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -6,399 | 94.83 | 0 | -67 | 0 | 53,900 | D | | | | | | | | | | | | | | |
7/8/21 19:09 | 7/6/21 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -14,515 | 117.22 | 0 | -124 | 0 | 54,158 | D | | | | | | | | | | | | | | |
9/30/20 16:53 | 9/28/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -15,226 | 280.39 | 0 | -54 | 0 | 56,197 | D | | | | | | | | | | | | | | |
9/16/20 17:12 | 9/14/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -20,588 | 253.46 | 0 | -81 | 0 | 56,903 | D | | | | | | | | | | | | | | |
9/2/20 17:44 | 8/31/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -14,236 | 233.21 | 0 | -61 | 0 | 57,959 | D | | | | | | | | | | | | | | |
8/21/20 17:21 | 8/19/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -21,852 | 237.06 | 0 | -92 | 0 | 58,752 | D | | | | | | | | | | | | | | |
8/14/20 17:30 | 8/12/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -9,140 | 212.71 | 0 | -43 | 0 | 59,951 | D | | | | | | | | | | | | | | |
8/5/20 17:43 | 8/5/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -3,852 | 223.27 | 0 | -17 | 0 | 60,509 | D | | | | | | | | | | | | | | |
8/5/20 17:30 | 8/3/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -8,975 | 221.27 | 0 | -41 | 0 | 60,733 | D | | | | | | | | | | | | | | |
7/22/20 18:22 | 7/22/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -6,614 | 238.34 | 0 | -28 | 0 | 61,261 | D | | | | | | | | | | | | | | |
7/22/20 18:14 | 7/20/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -13,895 | 251.84 | 0 | -55 | 0 | 61,621 | D | | | | | | | | | | | | | | |
7/8/20 17:20 | 7/6/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -10,735 | 199.12 | 0 | -54 | 0 | 62,339 | D | | | | | | | | | | | | | | |
7/1/20 16:43 | 6/29/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -1,007 | 191.85 | 0 | -5 | 0 | 63,040 | D | | | | | | | | | | | | | | |
6/24/20 20:23 | 6/22/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -7,386 | 185.90 | 0 | -40 | 0 | 63,108 | D | | | | | | | | | | | | | | |
6/12/20 16:14 | 6/10/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -158 | 175.07 | 0 | -1 | 0 | 63,624 | D | | | | | | | | | | | | | | |
5/5/20 16:48 | 5/1/20 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -656 | 141.43 | 0 | -5 | 0 | 63,636 | D | | | | | | | | | | | | | | |
12/19/19 16:10 | 12/17/19 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -10,000 | 160.62 | 0 | -62 | 0 | 63,696 | D | | | | | | | | | | | | | | |
7/9/19 19:23 | 7/8/19 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -394 | 126.87 | 0 | -3 | 0 | 64,506 | D | | | | | | | | | | | | | | |
5/2/19 16:07 | 5/1/19 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -354 | 125.18 | 0 | -3 | 0 | 64,546 | D | | | | | | | | | | | | | | |
3/6/19 18:32 | 3/4/19 | BGNE | Beigene, Ltd. | | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -3,869 | 151.73 | 0 | -25 | 0 | 64,583 | M | | | | | | | | | | | | | | |
12/12/18 17:28 | 12/10/18 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S | -562 | 135.78 | 0 | -4 | 0 | 64,914 | I | | | | | | | | | | | | | | |
11/28/18 19:26 | 11/26/18 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | S.m | -4,194 | 143.66 | 0 | -29 | 0 | 64,918 | I | | | | | | | | | | | | | | |
7/17/18 17:02 | 7/16/18 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S | -418 | 164.12 | 0 | -3 | 0 | 65,348 | D | | | | | | | | | | | | | | |
3/2/18 18:42 | 2/28/18 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -14,417 | 145.63 | 0 | -99 | 0 | 64,618 | D | | | | | | | | | | | | | | |
12/28/17 17:49 | 12/26/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S | -1,943 | 96.47 | 0 | -20 | 0 | 63,300 | D | | | | | | | | | | | | | | |
12/8/17 17:57 | 12/6/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -13,529 | 93.95 | 0 | -144 | 0 | 63,320 | D | | | | | | | | | | | | | | |
11/29/17 17:33 | 11/27/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -7,273 | 84.66 | 0 | -86 | 0 | 63,464 | D | | | | | | | | | | | | | | |
11/15/17 20:12 | 11/13/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -12,152 | 80.50 | 0 | -151 | 0 | 63,550 | D | | | | | | | | | | | | | | |
7/10/17 18:44 | 7/6/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S | -14,221 | 64.82 | 0 | -219 | 0 | 69,186 | D | | | | | | | | | | | | | | |
6/26/17 20:38 | 6/22/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -4,350 | 44.16 | 0 | -99 | 0 | 71,476 | D | | | | | | | | | | | | | | |
5/1/17 19:44 | 4/27/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -1,463 | 40.47 | 3 | -36 | 0 | 71,574 | D | | 52 | 24 | 12 | 3 | 10 | 11 | 4 | 0 | -3 | | | | |
3/20/17 19:06 | 3/16/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -1,260 | 39.39 | 4 | -32 | 0 | 71,610 | D | | 52 | 22 | 37 | 10 | 4 | -1 | 1 | -4 | -8 | -7 | | | |
3/6/17 19:00 | 3/2/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -4,459 | 40.91 | 5 | -109 | 0 | 73,059 | D | | 27 | 42 | 29 | 27 | 13 | 3 | 5 | -1 | 0 | -8 | | | |
2/21/17 19:23 | 2/16/17 | BGNE | Beigene, Ltd. | E9 | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DOT | CEO | S.m | -2,634 | 40.55 | 4 | -65 | 0 | 73,168 | D | | 51 | 42 | 10 | 32 | 19 | 13 | 8 | 0 | -4 | -4 | | | |